학술논문
'학술논문'
에서 검색결과 181건 | 목록
1~10
Academic Journal
Engert, A; Balduini, C; Brand, A; Coiffier, B; Cordonnier, C; Dohner, H; de Wit, TD; Eichinger, S; Fibbe, W; Green, T; de Haas, F; Iolascon, A; Jaffredo, T; Rodeghiero, F; Salles, G; Schuringa, JJ; Andre, M; Andre-Schmutz, I; Bacigalupo, A; Bochud, PY; den Boer, M; Bonini, C; Camaschella, C; Cant, A; Cappellini, MD; Cazzola, M; Lo Celso, C; Dimopoulos, M; Douay, L; Dzierzak, E; Einsele, H; Ferreri, A; De Franceschi, L; Gaulard, P; Gottgens, B; Greinacher, A; Gresele, P; Gribben, J; de Haan, G; Hansen, JB; Hochhaus, A; Kadir, R; Kaveri, S; Kouskoff, V; Kuhne, T; Kyrle, P; Ljungman, P; Maschmeyer, G; Mendez-Ferrer, S; Milsom, M; Mummery, C; Ossenkoppele, G; Pecci, A; Peyvandi, F; Philipsen, S; Reitsma, P; Ribera, JM; Risitano, A; Rivella, S; Ruf, W; Schroeder, T; Scully, M; Socie, G; Staal, F; Stanworth, S; Stauder, R; Stilgenbauer, S; Tamary, H; Theilgaard-Monch, K; Thein, SL; Tilly, H; Trneny, M; Vainchenker, W; Vannucchi, AM; Viscoli, C; Vrielink, H; Zaaijer, H; Zanella, A; Zolla, L; Zwaginga, JJ; Martinez, PA; van den Akker, E; Allard, S; Anagnou, N; Andolfo, I; Andrau, JC; Angelucci, E; Anstee, D; Aurer, I; Avet-Loiseau, H; Aydinok, Y; Bakchoul, T; Balduini, A; Barcellini, W; Baruch, D; Baruchel, A; Bayry, J; Bento, C; van den Berg, A; Bernardi, R; Bianchi, P; Bigas, A; Biondi, A; Bohonek, M; Bonnet, D; Borchmann, P; Borregaard, N; Braekkan, S; van den Brink, M; Brodin, E; Bullinger, L; Buske, C; Butzeck, B; Cammenga, J; Campo, E; Carbone, A; Cervantes, F; Cesaro, S; Charbord, P; Claas, F; Cohen, H; Conard, J; Coppo, P; Corrons, JLV; da Costa, L; Davi, F; Delwel, R; Dianzani, I; Domanovic, D; Donnelly, P; Drnovsek, TD; Dreyling, M; Du, MQ; Dufour, C; Durand, C; Efremov, D; Eleftheriou, A; Elion, J; Emonts, M; Engelhardt, M; Ezine, S; Falkenburg, F; Favier, R; Federico, M; Fenaux, P; Fitzgibbon, J; Flygare, J; Foa, R; Forrester, L; Galacteros, F; Garagiola, I; Gardiner, C; Garraud, O; van Geet, C; Geiger, H; Geissler, J; Germing, U; Ghevaert, C; Girelli, D; Godeau, B; Gokbuget, N; Goldschmidt, H; Goodeve, A; Graf, T; Graziadei, G; Griesshammer, M; Gruel, Y; Guilhot, F; von Gunten, S; Gyssens, I; Halter, J; Harrison, C; Harteveld, C; Hellstrom-Lindberg, E; Hermine, O; Higgs, D; Hillmen, P; Hirsch, H; Hoskin, P; Huls, G; Inati, A; Johnson, P; Kattamis, A; Kiefel, V; Kleanthous, M; Klump, H; Krause, D; Hovinga, JK; Lacaud, G; Lacroix-Desmazes, S; Landman-Parker, J; LeGouill, S; Lenz, G; von Lilienfeld-Toal, M; von Lindern, M; Lopez-Guillermo, A; Lopriore, E; Lozano, M; MacIntyre, E; Makris, M; Martens, J; Mathas, S; Matzdorff, A; Medvinsky, A; Menendez, P; Migliaccio, AR; Miharada, K; Mikulska, M; Minard, V; Montalban, C; de Montalembert, M; Montserrat, E; Morange, PE; Mountford, J; Muckenthaler, M; Muller-Tidow, C; Mumford, A; Nadel, B; Navarro, JT; el Nemer, W; Noizat-Pirenne, F; O'Mahony, B; Oldenburg, J; Olsson, M; Oostendorp, R; Palumbo, A; Passamonti, F; Patient, R; de Latour, RP; Pflumio, F; Pierelli, L; Piga, A; Pollard, D; Raaijmakers, M; Radford, J; Rambach, R; Rao, AK; Raslova, H; Rebulla, P; Rees, D; Ribrag, V; Rijneveld, A; Rinalducci, S; Robak, T; Roberts, I; Rodrigues, C; Rosendaal, F; Rosenwald, A; Rule, S; Russo, R; Saglio, G; Sanchez, M; Scharf, RE; Schlenke, P; Semple, J; Sierra, J; So-Osman, C; Soria, JM; Stamatopoulos, K; Stegmayr, B; Stunnenberg, H; Swinkels, D; Barata, JPT; Taghon, T; Taher, A; Terpos, E; Thachil, J; Tissot, JD; Touw, I; Toye, A; Trappe, R; Traverse-Glehen, A; Unal, S; Vaulont, S; Viprakasit, V; Vitolo, U; van Wijk, R; Wojtowicz, A; Zeerleder, S; Zieger, B
Haematologica. 101(2):115-208
Academic Journal
LBL Miranda; NO Rossini; K Lima; DA Pereir-Martins; JJ Schuringa; EM Rego; F Traina; MVB Dias; JA Machad-Neto
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S220- (2023)
IDENTIFICAÇÃO DE VULNERABILIDADES PARA INIBIÇÃO FARMACOLÓGICA DAS PIP4K2S EM LEUCEMIA MIELOIDE AGUDA
Academic Journal
K Lima; MFL Carvalho; DA Pereir-Martins; LBL Miranda; MCD Nascimento; FL Nogueira; RC Cavaglieri; JJ Schuringa; JA Machad-Neto; EM Rego
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S237- (2023)
Academic Journal
K Lima; MFL Carvalho; DA Pereir-Martins; WF Silva; MCD Nascimento; LBL Miranda; RC Cavaglieri; L Nardinelli; AM Leal; EDRP Velloso; I Bendit; JJ Schuringa; JA Machad-Neto; EM Rego
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S236- (2023)
Academic Journal
MCD Nascimento; DA Pereir-Martins; GAS Alcântara; KC Lima; HP Vicari; MJP Ferreira; LV Cost-Lotufo; GA Huls; JJ Schuringa; JA Machad-Neto; EM Rego
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S307- (2023)
Academic Journal
Kwon MC; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Thuring JW; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Querolle O; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Dai X; Discovery Product Development and Supply, Janssen R&D, Shanghai, China.; Verhulst T; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Pande V; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Marien A; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Goffin D; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Wenge DV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Jin C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Shaffer PL; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Jacobs F; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Vinken P; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Cai W; Discovery Product Development and Supply, Janssen R&D, Shanghai, China.; Keersmaekers V; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Eyassu F; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Bhogal B; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Verstraeten K; Discovery Oncology, Janssen R&D, Beerse, Belgium.; El Ashkar S; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Jayaguru P; Translational Research, Janssen R&D, Spring House, PA.; Barreyro L; Translational Research, Janssen R&D, Spring House, PA.; Kuchnio A; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Darville N; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Krosky D; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Urbanietz G; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Verbist B; TMEDS, Janssen R&D, Beerse, Belgium.; Edwards JP; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Cowley GS; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Kirkpatrick R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Steele R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Ferrante L; Early Development, Janssen R&D, Spring House, PA.; Guttke C; Translational Research, Janssen R&D, Spring House, PA.; Daskalakis N; Early Development, Janssen R&D, Spring House, PA.; Pietsch EC; Discovery Oncology, Janssen R&D, Spring House, PA.; Wilson DM; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Attar R; Translational Research, Janssen R&D, Spring House, PA.; Elsayed Y; Discovery Oncology, Janssen R&D, Spring House, PA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Packman K; Early Development, Janssen R&D, Cambridge, MA.; Philippar U; Discovery Oncology, Janssen R&D, Beerse, Belgium.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Dembitz V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Department of Physiology and Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.; Lawson H; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Burt R; Division of Cell and Molecular Biology, Imperial College London, London, UK.; Francis Crick Institute, London, UK.; Natani S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Philippe C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; INSERM U1242, University of Rennes, Rennes, France.; James SC; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Atkinson S; Division of Cell and Molecular Biology, Imperial College London, London, UK.; Francis Crick Institute, London, UK.; Durko J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Wang LM; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Campos J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Magee AMS; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Woodley K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Austin MJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Experimental Hematology Lab, IIS-Fundación Jimenez Díaz, UAM, Madrid, Spain.; Casado P; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Bewicke-Copley F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rodriguez Blanco G; The University of Edinburgh MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Pereira-Martins D; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Oudejans L; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Boet E; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, LabEx Toucan, Toulouse, France.; Équipe labellisée Ligue Nationale Contre le Cancer 2023, Toulouse, France.; von Kriegsheim A; The University of Edinburgh MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Schwaller J; University Children's Hospital and Department of Biomedicine (DBM), University of Basel, Basel, Switzerland.; Finch AJ; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Patel B; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sarry JE; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, LabEx Toucan, Toulouse, France.; Équipe labellisée Ligue Nationale Contre le Cancer 2023, Toulouse, France.; Tamburini J; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva and Swiss Cancer Center Leman, Geneva, Switzerland.; Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Hazlehurst L; Modulation Therapeutics, Morgantown, WV, USA.; Copland Iii JA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.; Yuneva M; Francis Crick Institute, London, UK.; Peck B; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Cutillas P; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Fitzgibbon J; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rouault-Pierre K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Kranc K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK.; Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. p.gallipoli@qmul.ac.uk.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Lima K; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: kelilima@usp.br.; Nogueira FL; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Cipelli M; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Carvalho MFL; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Pereira-Martins DA; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; da Silva WF; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Cavaglieri RC; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Leal AM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Velloso EDRP; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Bendit I; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Câmara NOS; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Schuringa JJ; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: jamachadoneto@usp.br.; Rego EM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil. Electronic address: eduardo.rego@fm.usp.br.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Academic Journal
Groenen AG; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Halmos B; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; van Zeventer IA; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Salzbrunn JB; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Mayer ML; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; La Rose ND; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Nolte IM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Schuringa JJ; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Huls G; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Westerterp M; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.westerterp@umcg.nl.
Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE
Editorial & Opinion
Salustiano-Bandeira ML; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Moreira-Aguiar A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Weinhäuser I; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; França-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Lima AS; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Lima AS; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Baccarin AR; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Silva FB; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; de Melo MA; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Niemann FS; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Nardinelli L; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Ortiz Rojas CA; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Duarte BK; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Department of Internal Medicine, University of Campinas, Campinas, Brazil.; Araujo AS; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.; Azevedo EA; Department of Virology, Fundação Oswaldo Cruz, Instituto de Pesquisas Aggeu Magalhães, Recife, Brazil.; Morais CN; Department of Virology, Fundação Oswaldo Cruz, Instituto de Pesquisas Aggeu Magalhães, Recife, Brazil.; Figueiredo-Pontes LL; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Huls G; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Bendit I; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Rego EM; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.; Olalla Saad ST; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Department of Internal Medicine, University of Campinas, Campinas, Brazil.; Traina F; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Bezerra MA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil. antonio.araujo@ufpe.br.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Schuringa, JJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어